Minutes for the Research for Patient Benefit (RfPB) programme West Midlands Regional Advisory Committee meeting to discuss applications to Competition 43 Stage 2 and Competition 44 Stage 1.
Date and Location
Wednesday 26 May 2021 Virtual Meeting
In attendance
Committee Members
Dr Rebecca Kearney(Chair)
Dr Srikanth Bellary
Dr Opeyemi Babatunde
Dr Milica Blagojevic-Bucknall
Professor Matthew Brookes Professor Julie Bruce Ms Lynne Carney
Dr Keith Couper
Dr Sarah Damery
Professor Thomas Dietrich
Mr Adrian Gardner
Dr Francis Gilchrist
Dr Katie Newby
Professor Thomas Pinkney
Dr Alice Sitch
Dr Jane Warwick
Ms Helen Weatherly
Dr Simon White
Secretariat
Mrs Nishita Nair (NIHR CCF)
Mr Ben Morgan (NIHR CCF)
Dr Ianina Conte (NIHR CCF)
Ms Lara Oh (NIHR CCF)
Mr Marc Browne (NIHR CCF)
Professor Sue Ziebland (Programme Director)
Observers
Dr Doyo Gragn Enki RDS - EM
Dr Gary Hickey RDS - SE
Apologies were received from Dr Susan Hunter, Dr Steven Marwaha and Professor Nachiappan Chockalingam
Stage 2 applications considered
1.1 NIHR202810: A pilot study to assess the safety, effectiveness and, practical utility of remote patient monitoring to guide the timing of valve intervention in patients with asymptomatic severe aortic stenosis (APRAISE-AS)
Conflicts: Dr Alice Sitch, Dr Sarah Damery, Mr Adrian Gardner, Professor Thomas Pinkney and Professor Matthew Brookes.
Final outcome: Conditional support
1.2 NIHR202839: Providing tailored interventions for anxiety and psychosis symptoms in people with early psychosis and autistic traits by Aligning Dimensions of Interoceptive Experiences: The ADIEp in Psychosis multi-site feasibility RCT
Conflicts: None
Final outcome: Reject
1.3 NIHR202816: Testing the acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study
Conflicts: Dr Alice Sitch, Dr Sarah Damery, Professor Thomas Pinkney, Mr Adrian Gardner, Dr Srikanth Bellary, Dr Keith Couper and Professor Rebecca Kearney (Chair). Professor Matthew Brookes assumed the Chair
Final outcome: Conditional support
1.4 NIHR202800: Measuring fatigue in Axial Spondyloarthritis (axSpA): refinement, application and evaluation of a new electronic patient-reported outcome measure (the Warwick Axial Spondyloarthritis Fatigue and Energy questionnaire (e-WASTEd)) in rheumatology clinical practice
Conflicts: Dr Keith Couper, Professor Rebecca Kearney (Chair), Professor Julie Bruce and Professor Jane Warwick. Professor Thomas Pinkney assumed the Chair
Final outcome: Conditional support
Stage 1 applications considered
2.1 NIHR203060: Short-term Psycho-Education for Carers To Reduce Over Medication of people with intellectual disabilities: Implementation and Feasibility trial (SPECTROM-IF)
Conflicts: None
Outcome: Invite to Stage 2
2.2 NIHR203161: The feasibility and implementation of a psychosis risk prediction algorithm (P Risk) for use in primary care
Conflicts: None
Outcome: Invite to Stage 2
2.3 NIHR203119: Developing and evaluating the feasibility of home-based eccentric exercises in older repeat fallers: A co-production approach
Conflicts: Professor Julie Bruce
Outcome: Reject
2.4 NIHR203099: The Patient Path to a diagnosis of Atrial Fibrillation: a qualitative study in primary care (P-PAF)
Conflicts: Professor Julie Bruce, Dr Alice Sitch, Professor Jane Warwick, Dr Keith Couper and Professor Rebecca Kearney (Chair). Professor Thomas Pinkney assumed the Chair
Outcome: Invite to Stage 2
2.5 NIHR203063: A systematic review of body-oriented psychological therapies for the treatment of eating disorders - evidence synthesis with stakeholder engagement to formulate care and research recommendations
Conflicts: Mr Adrian Gardner
Outcome: Reject
2.6 NIHR203172: The COALESCE study - Creating a natiOnAL CNS PancrEatic Cancer ReSearCh Network to standardisE and improve care: A feasibility study
Conflicts: Mr Adrian Gardner, Dr Alice Sitch, Dr Sarah Damery, Professor Matthew Brookes, Professor Thomas Pinkney and Dr Keith Couper
Outcome: Invite to Stage 2
2.7 NIHR203069: CO-DEsign of a Social Determinants of Health General Practice Tool (CODE SDH Tool)
Conflicts: None
Outcome: Reject
2.8 NIHR203213: Precision medicine in dementia: Individual-level prediction of cardiovascular side effects following risperidone treatment
Conflicts: None
Outcome: Reject
2.9 NIHR203106: Hearing from the unheard: impact of long-COVID in minority ethnic groups in the UK (Hi-COVE)
Conflicts: Dr Sarah Damery, Dr Opeyemi Babatunde, Professor Julie Bruce and Dr Simon White
Outcome: Invite to Stage 2
2.10 NIHR203166: Investigating the impact of common prescription drugs on the effectiveness of routine vaccines in adults with chronic conditions: an evidence synthesis
Conflicts: Professor Julie Bruce and Ms Helen Weatherly
Outcome: Reject
2.11 NIHR203070: Improving outcomes for those living with multi-morbidity by enabling identification and response to patient and family carer support needs: The SUPPORT feasibility study
Conflicts: None
Outcome: Reject
2.12 NIHR203038: Does mobilisation in the evening reduce the incidence of delirium in patients admitted to intensive care: a mixed methods, randomised controlled feasibility study
Conflicts: Professor Julie Bruce and Professor Rebecca Kearney (Chair). Professor Thomas Pinkney assumed the Chair
Outcome: Reject
2.13 NIHR203061: A multi-centre, randomised feasibility study of the acceptability, tolerability and patient preferences of current treatment options for recurrent urinary tract infections, using validated International Consultation on Incontinence Questionnaire (ICIQ) quality of life and symptom questionnaires
Conflicts: Dr Sarah Damery, Dr Opeyemi Babatunde, Dr Francis Gilchrist and Dr Simon White
Outcome: Reject
Outcomes tables
The tables below display the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 6-10, although a score of 6-10 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.
In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 7.
Competition 44 Stage 1
|
Score |
Range |
Number of applications |
|---|---|---|
| 9-10 | Invited | 0 |
| 8 | Invited | 0 |
| 7 | Invited | 3 |
| 6 | Invited | 2 |
| 5 | Rejected | 5 |
| 4 | Rejected | 2 |
| 3 | Rejected | 1 |
| 2 | Rejected | 0 |
| 1 | Rejected | 0 |
Competition 43 Stage 2
|
Score |
Range |
Number of applications |
|---|---|---|
| 9-10 | Fundable | 0 |
| 8 | Fundable | 0 |
| 7 | Fundable | 3 |
| 6 | Fundable | 0 |
| 5 | Rejected | 0 |
| 4 | Rejected | 1 |
| 3 | Rejected | 0 |
| 2 | Rejected | 0 |
| 1 | Rejected | 0 |